)
Connect Biopharma Holdings (CNTB) investor relations material
Connect Biopharma Holdings Evercore ISI 8th Annual HealthCONx Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and product differentiation
Developing a next-generation IL-4 receptor alpha monoclonal antibody, retimicavir, with rapid onset and unique binding properties, designed for atopic dermatitis and asthma.
Demonstrates efficacy in both atopic dermatitis and asthma, with a longer dosing interval and a different safety profile compared to Dupixent, notably reducing eosinophil counts.
Licensed to a major Chinese pharmaceutical company for development in China, with NDA filed for atopic dermatitis and phase 3 asthma study ongoing.
Market opportunity and strategy
Acute care setting for asthma and COPD identified as a major unmet need, with approximately four million acute episodes annually in the U.S.
Acute treatment in emergency and urgent care settings seen as a gateway to chronic use, potentially leading to multi-billion dollar commercial opportunity.
Differentiation from competitors by targeting acute exacerbations, where no other biologics are approved or recommended.
Clinical development and trial design
Two global phase 2 studies underway for acute asthma and COPD exacerbations, each targeting 160 patients, with data expected in the first half of next year.
Primary endpoint is treatment failure within 28 days, aiming for a 50% reduction in return visits compared to a 45% control rate.
Confident in trial powering based on contemporary data, with expectations of rapid onset translating to superior outcomes.
Interim analysis pending, to be conducted at halfway enrollment.
Next Connect Biopharma Holdings earnings date
Next Connect Biopharma Holdings earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)